FDA Clearance Tracker · P250055
AMDS Hybrid Prosthesis
Last checked: Nov 19, 2026Latest source record: Jun 26, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jun 26, 2026
Approved
Time to decision
179 days
Received Dec 29, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P250055
- Device name
- AMDS Hybrid Prosthesis
- Applicant
- Artivion, Inc.
- Applicant location
- Kennesaw, GA
- Received
- Dec 29, 2025
- Decided
- Jun 26, 2026
- Decision
- Approved
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
The AMDS Hybrid Prosthesis is indicated for use in patients with acute DeBakey Type I aortic dissections with malperfusion (including cerebral, visceral, renal, and peripheral malperfusion) and a primary entry tear within the ascending aorta proximal to the innominate artery, who are undergoing open surgical repair within 0-14 days of diagnosis.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QSK. The earliest in FDA's data is P210006, decided Apr 19, 2022.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Artivion, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K252059 · Decided Oct 2, 2025 · 93 days after receipt
Device type: Heart Valve, More Than Minimally Manipulated Allograft (OHA) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.